Lavipharm S.A. | Balance Sheet
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,217.00
2,437.00
2,057.00
1,675.00
2,348.00
1,842
Total Accounts Receivable
20,649.00
13,242.00
13,906.00
13,077.00
11,338.00
11,879
Inventories
4,958.00
3,854.00
4,824.00
6,287.00
5,763.00
4,900
Other Current Assets
135.00
285.00
-
228.00
417.00
-
Total Current Assets
29,959.00
19,818.00
20,787.00
21,267.00
19,866.00
18,621
Net Property, Plant & Equipment
23,294.00
23,024.00
22,404.00
18,595.00
15,276.00
15,329
Total Investments and Advances
1,971.00
2,101.00
1,585.00
1,453.00
2,086.00
2,086
Long-Term Note Receivable
7,425.00
939.00
781.00
483.00
605.00
597
Intangible Assets
40,608.00
31,067.00
30,261.00
2,889.00
3,096.00
2,667
Other Assets
-
-
201.00
-
-
320
Total Assets
108,036.00
83,824.00
82,379.00
48,719.00
44,900.00
41,897
ST Debt & Current Portion LT Debt
38,544.00
53,669.00
62,773.00
22,304.00
1,709.00
Accounts Payable
9,770.00
7,437.00
7,224.00
3,944.00
3,444.00
Income Tax Payable
895.00
281.00
157.00
91.00
443.00
Other Current Liabilities
17,751.00
17,378.00
16,899.00
15,566.00
13,901.00
Total Current Liabilities
66,960.00
78,765.00
87,053.00
41,905.00
19,497.00
Long-Term Debt
52,550.00
48,393.00
51,477.00
56,761.00
39,773.00
Provision for Risks & Charges
2,857.00
3,200.00
3,150.00
2,235.00
1,804.00
Deferred Taxes
4,779.00
6,875.00
6,360.00
3,490.00
3,879.00
Other Liabilities
633.00
2,430.00
5,119.00
4,192.00
3,672.00
Total Liabilities
123,000.00
132,788.00
146,799.00
105,635.00
64,838.00
Common Equity (Total)
1,536.00
25,997.00
35,849.00
31,825.00
19,919.00
Total Shareholders' Equity
1,536.00
25,997.00
35,849.00
31,825.00
19,919.00
Total Equity
14,964.00
48,964.00
64,420.00
56,916.00
19,938.00
Liabilities & Shareholders' Equity
108,036.00
83,824.00
82,379.00
48,719.00
44,900.00
Accumulated Minority Interest
13,428.00
22,967.00
28,571.00
25,091.00
19.00
About Lavipharm
View Profile
